Evidence has accumulated that cyclic AMP (cAMP)-induced phosphorylation of a Ras-related protein (Rap 1) regulates platelet Ca2+ transport. As this transport was recently found to be controlled by two isoforms of sarcoendoplasmic reticulum Ca2+-ATPase (SERCA), the 100 kDa SERCA2b and the newly identified 97 kDa SERCA, we attempted to establish which isoform is involved in this regulation. For this purpose, we studied the expression and regulation of both the SERCA and RapI isoforms in platelets, haemopoietic cells and various cancer cell lines. SERCA2b was shown-to be equally expressed in all the cell lines tested, as determined by detection of its phosphoenzyme formation and by Western blotting using an isoform-specific antibody. In contrast,. the expression of the 97 kDa SERCA, studied by the same methods, varied from total absence in the cancer cells to high levels in the megakaryocytic cell lines. With regard to the potential regulatory Rapl proteins, Western
INTRODUCTION
Cytosolic Ca2+ concentration plays an important role in platelet function. An increase in this concentration is a necessary event for platelet activation, which involves a shape change and exocytosis processes leading to aggregation [1] [2] [3] [4] . This increase in cytosolic Ca2+ concentration is brought about by both Ca2+ influx from the extracellular medium and inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release from intracellular Ca2+ stores [5, 6] , and is controlled by a specific Ca2+-ATPase system. Thus cells generally express both plasma-membrane Ca2+-ATPases, which extrude Ca2+ ions from the cell [7] , and sarcoendoplasmic reticulum Ca2+-ATPases (SERCAs), which sequester Ca2+ in intracellular Ca2+ pools [8] . In platelets, the Ca2+-ATPase system was recently demonstrated to consist of two distinct isoforms of the SERCA family, the 100 kDa SERCA2b isoform and an as yet unidentified 97 kDa SERCA isoform [9-1 1] .
Platelet activation can be reversed by triggering agents which raise the level of cyclic AMP (cAMP) which is known to activate cAMP-dependent protein kinase. As this reversal was found to be associated with a decrease in intracellular Ca2+ concentration, it was thought to occur through regulation of a Ca2+-dependent process such as an action on Ca2+-ATPases [12, 13] . An interesting early finding was that the addition of cAMP to a cytosolic fraction containing cAMP-dependent protein kinase stimulated platelet Ca2+ transport and phosphorylated a 22-24 kDa protein blotting showed different expression of total Rapl isoforms among the cell lineages, thus ruling out any possible relationship between RapI and SERCA2b. However, the expression of Rapl proteins correlated with that of the 97 kDa SERCA isoform. More refined analysis of the raplA and raplB isoforms by reverse transcription PCR and by determining cAMP-induced phosphorylation of RaplB, i.e. its functional mechanism, confirmed the correlation between RaplB and the 97 kDa SERCA expression. This relationship was also established by the concerted up-regulation of these two proteins demonstrated in the pathological model of platelets from hypertensive rats. It is concluded that the expressions of 97 kDa SERCA and RaplB are related, suggesting that regulation of the platelet Ca2+-ATPase system by cAMP-induced phosphorylation of RaplB specifically involves the 97 kDa SERCA. [14] . Various authors subsequently confirmed this finding, using different approaches. First, Fox et al. [15, 16] treated intact platelets with agents that increased the cAMP level, and demonstrated that a 22 kDa membrane protein was phosphorylated concomitantly with an increase in Ca2l uptake mediated by the Ca2+-ATPases. This effect of cAMP on both the phosphorylation of a 22 kDa protein and Ca2+ uptake was further confirmed by treating isolated membrane vesicles with the purified catalytic subunit of the cAMP-dependent protein kinase (C.Sub.) [17] [18] [19] . However, this correlation between phosphorylation of the 22 kDa protein and Ca2+ transport was recently the subject of some controversy [20] [21] [22] , based on two observations: first, the C.Sub. did not stimulate Ca2+ uptake [20, 21] , and secondly, the time course of cAMP-induced phosphorylation of the 24 kDa protein was different from that of the regulation of Ca2+-ATPase [22] . The first studies showed that the increased uptake of Ca2+ correlated with the phosphate concentration of the commercial C.Sub. solution, and not with its enzyme activity [20, 21] . However, this cannot explain the results obtained with membrane fractions isolated from platelets previously treated with cAMPenhancing agents and without using C.Sub. [15, 16] . In the third study, Fischer and White [22] used very short phosphorylation times, and subsequent studies have now clearly demonstrated that the 22 kDa protein cannot be phosphorylated under these conditions [23] , highlighting the issue of the identity of the protein involved.
The presence of low-molecular-mass GTP-binding proteins has been demonstrated in human platelets [24] [25] [26] [27] [28] [29] ; one of these proteins was phosphorylated in vivo in response to an increase in cAMP concentration in intact platelets induced by prostaglandin E1, and in vitro by the cAMP-dependent protein kinase [29] . This GTP-binding protein was also found to be Ras-related [28, 30, 31] and the most recent studies established its identity precisely as a Rapl protein [32, 33] . As Rapl proteins themselves consist of two isoforms, RaplA and RaplB [34] [35] [36] , the initially described cAMP-induced 22 [38] proposed that Rap lB might form a complex with Ras-GTPase-activating protein and serve as a signal to recruit phospholipase Cyl to the cell membrane, where it can act on membrane-bound inositol phospholipids. Thus, the aim of the present study was to advance the understanding of the role of RaplB in platelet function by further investigating its role in Ca2+-ATPase activity. To do this, we first attempted to establish which of the two newly distinguished platelet Ca2+-ATPases is the target of the RaplB protein, using an approach based on the hypothesis that, if this protein really regulates the activity of Ca2+-ATPases, the expression and regulation of the interrelated proteins should be concerted.
We thus investigated the possible relationship between the expression of Rapl and SERCA proteins by testing their relative expression and regulation in platelets and selected cell lines. The presence of the different SERCA isoforms and their levels of expression were studied by the detection of specific Ca2+-ATPase phosphoenzymes and by Western blotting with SERCA isoformspecific antibodies. For Rapl proteins, we first tested the total expression of RaplA and RaplB isoforms by Western blotting, using an anti-Rapl antibody. Next, we assayed the RaplB protein by studying its cAMP-induced phosphorylation on isolated membranes, and comparing the mRNA levels corresponding to the raplA and raplB isoforms by PCR followed by Southern blotting with specific cDNA probes. The overall results showed that the 100 and 97 kDa platelet-type Ca2+-ATPases are differentially expressed in platelets and various cell lines. In addition, the expression of the 97 kDa SERCA clearly correlated with that of the regulatory protein, Rapl, and more specifically with that of its RaplB isoform.
EXPERIMENTAL

Cell culture
This study was conducted on human platelets and the following human cell lines: Dami (megakaryoblastoid [39] ), HEL (human erythroleukaemic [40] ), Human platelet membranes were prepared by a similar method, as described previously [33, 42] , and platelet membranes from spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were isolated as described by Papp et al. [43] .
Formation of the phosphorylated Intermediate (E P) of Ca2+-ATPases Ca2+-ATPases of various cell membranes were autophosphorylated on ice in a reaction buffer containing 17 mM Hepes, pH 7, 160 mM KCI, 1 [9] . After electrophoresis, proteins were transferred on to nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany) and autoradiographed for 48 h at -80 'C using Kodak X-Omat AR films.
Antibody characteristics
The IID8 and PL/IM 430 anti-Ca2+-ATPase monoclonal antibodies were kindly given by Dr. K. Campbell, Iowa City, IO, U.S.A. and Dr. N. Crawford, London, U.K. respectively. 1ID8 is a mouse monoclonal antibody raised against dog cardiac muscle SERCA by Grover et al. [44] . This antibody recognized a shared epitope present on cardiac muscle (SERCA2a) as well as on smooth muscle (SERCA2b [45] ). PL/IM 430 was elicited against platelet internal membranes, inhibited the active Ca2+ transport across these membranes [46] and specifically recognized the 97 kDa SERCA isoform [11] .
Anti-Rap antibody was elicited in rabbits against a synthetic peptide encompassing residues 121-137 of RapI and common to both RaplA and RaplB. The preparation and specificity of this antibody have both been previously described [47] , and it has been purified on an agarose column coupled to the immunizing III, DU 4475 and Y79 cells were grown in RPMI 1640 medium peptide. Briefly, the anti-Rap I antibody recognized and immuno-precipitated a single band of22 kDa in extracts from recombinant bacteria induced to produce RaplA in Rat-I fibroblasts and in HL-60 cells, which amply express this isoform [48] . Neither recombinant Rap2 nor Ha-Ras proteins reacted with this antibody. cAMP-induced phosphorylated proteins were reduced with 5 % 2-mercaptoethanol, separated by SDS/PAGE (11 % gels), electroblotted on to nitrocellulose membranes, and autoradiographed for 24-48 h at -80 'C using Kodak X-Omat AR films.
SDS/PAGE and
RNA extraction
Total RNA was isolated from various cell lines as described by Chomczynski and Sacchi [49] . Briefly, cells were lysed using guanidinium thiocyanate denaturing solution. RNA was then extracted at 4 'C with phenol/chloroform, precipitated with propan-2-ol, analysed on 1 % agarose gel and stored at -80 'C. PCR For raplA and raplB amplification, two synthetic 3' primers (21-mer) were chosen in the non-conserved region (bp 508-528 for both) to ensure that they were specifically complementary to either the raplA or raplB nucleotide sequences. As regards the 5' primer, a 23-mer oligonucleotide (bp 167-189) that was common to both sequences was designed. For SERCA2b amplification, we used two synthetic primers (bp 3110-3130 for the 3' primer and bp 2861-2882 for the 5' primer), the 3' primer being located in the 3' region of the mRNA, after the splicing site, because the SERCA2b isoform and the cardiac muscle isoform, SERCA2a, have a common sequence up to the 2980 bp site of the 3' end region, but thereafter their sequences differ.
Total RNA template (250 ng) was denatured by heating to 75°C for 3 min and annealed to 21 pmol of the 3' primers corresponding to raplA, rap lB and SERCA2b respectively, by slow cooling to 30 'C. Reverse transcription was carried out by adding to this preparation 200 units of murine Moloney leukaemia virus reverse transcriptase (MMLV-RT) (USB, Cleveland, OH, U.S.A.) and incubating it for 1 h at 42 'C in PCR buffer containing 10 mM Tris/HCl, pH 8.3, 50 mM KCI, 2.5 mM MgCl2, 0.001 % gelatin and 2.5 mM each dATP, dTTP, dCTP and dGTP, in a total volume of 20 ll. Reverse transcription was terminated by heat-inactivating the MMLV-RT for 10 min at 95 'C. The PCR, first described by Saiki et al. [50] , was carried out in the same reaction mixture, adjusted to 100,u with the PCR buffer containing 20 pmol of the 5' primers (raplA, raplB and SERCA2b) and 2.5 units of Taq polymerase (Boehringer). PCR consisted of denaturation at 95 0C for 45 s, annealing at 55 'C for 1 min and extension at 70 0C for 2 min, for 35 cycles, in an automated thermocycler (Hybaid, Teddington, Middx., U.K.). A negative control was run in the absence of reverse transcriptase, in order to check the specificity of the amplification.
Southern blotting
The PCR products (one-tenth of the reaction volume) were submitted to electrophoresis on 1.5 % ethidium bromide-stained agarose gel, and transferred on to Biohylon Z + membranes (Bioprobe, Montreuil-sous-Bois, France) as described by Sambrook et al. [51] . Membranes were prehybridized for 2 h at 65 'C in a hybridization oven, in the presence of the hybridization solution (5 x SSC, 5 x Denhardt's solution, 0.1 % SDS and 100 ug/ml denatured herring sperm DNA). Hybridization was performed overnight at 65 'C in the same solution in the presence of 2 x 106 c.p.m./ml of the labelled cDNA probes. The following three probes were labelled with [a-32P]dCTP by random priming (Random Priming DNA Labelling Kit, Boehringer): the raplA probe was a 760 bp HindlIl-EcoRI cDNA corresponding to total human rap lA [34] , the rap lB probe, a 730 bp HindIII-EcoRI cDNA totally covering human raplB [36] , and the SERCA2b probe, an 848 bp cDNA fragment of SERCA2b, obtained by screening of a human platelet cDNA library [10] . Membranes were washed twice at high stringency in 1 x SSC/0.1 % SDS for 20 min at 55 'C, and twice in 0.1 x SSC/0.1 % SDS for 20 min at 65 'C (55 'C for the SERCA2b probe). Southern blots were autoradiographed with Kodak X-Omat AR films for 2 h.
RESULTS
Formation of Ca2+-ATPase phosphorylated intermediates in various cell lines
To establish whether the 100 kDa SERCA2b or the 97 kDa SERCA platelet Ca2+-ATPase is the target of the Rapl protein regulating Ca2`transport, we looked for cells expressing one or both of these SERCAs, preferably in different amounts. For this purpose, our choice of cell lines was based on the results of our preliminary investigation, which showed that the 97 kDa SERCA was present in several haemopoietic cell lines and absent from a cancer cell line [11] . Consequently, we tested a panel of haemopoietic and cancer cell lines, and investigated isolated membranes for the presence of the different SERCA isoforms by following the formation of the phosphorylated intermediate (E P) complex corresponding to the transient step in the catalytic cycle of these isoforms (Figure 1 ). Two groups of cells can therefore be distinguished in terms of their Ca2+-ATPase systems. The first includes the haemopoietic cells, which express both the 100 kDa and 97 kDa SERCAs, and the second, the cancerous cells, which express only the 100 kDa Ca2+-ATPase.
Expression of SERCA2b and 97 kDa SERCA To check the exact identity of the Ca2+-ATPases corresponding to these two SERCAs, and to estimate their relative expression, we performed Western blotting of cell membranes. We used the 1ID8 and PL/IM 430 monoclonal antibodies previously shown to react specifically in human platelets with the 100 kDa SERCA2b and 97 kDa SERCA respectively [11] . The IID8 antibody recognized the 100 kDa band in all the cell lines tested (Figure 2a, lanes 0-10) ; the corresponding SERCA2b protein was expressed in similar amounts.
When the same cell membranes were then immunoblotted with the anti-(97 kDa SERCA) antibody PL/IM 430, the results established that the 97 kDa SERCA expressed in the haemopoietic cells (Figure 2b, lanes 0-4) (Figure 2b, lanes 6-10) . In addition, as expected with this fairly quantitative technique, large differences were found in the relative expression of this 97 kDa SERCA. It was interesting to note that its most abundant expression was in the haemopoietic cells, especially the megakaryocytic cells (platelets, Dami and HEL cells, lanes 0-2), but it was also detectable in the HeLa epithelial cells (lane 5). Thus, there were striking differences between the relative expression of SERCA2b and 97 kDa SERCA. Whereas SERCA2b seemed to be expressed equally in the different cell lines, the 97 kDa SERCA was expressed in a specific manner in the haemopoietic cells, even though its distribution in these cell types was heterogeneous.
Expression of Rapl proteins
To explore the possible relationship between the expression of Rapl and SERCA proteins, we first performed Western blots of cell membranes using the anti-Rapl antibody, which recognized a common epitope on both RaplA and Rap lB [47] , as described in the Experimental section. RapI proteins are known to display an electrophoretic-mobility shift which varies depending on whether reducing (24 kDa) or non-reducing conditions (22 kDa [33] ) are used. Total expression of RaplA and Rap lB (Figure 3) showed that the membranes isolated from all the cell types contained Rapl proteins (lanes 0-10), as indicated by the recognition of the 24 Total RNAs were extracted from platelets and the various cell lines as described in the Experimental section. Each RNA (250 ng) underwent reverse transcription using the specific 3' primers and MMLV-RT under the conditions described in the Experimental section. PCR was then performed and one-tenth of the amplification products were analysed by Southern blotting using, as probes, 32P-labelled cDNA of SERCA2b (a), raplA (b) and raptB (c). After different washing steps at high stringency, the blots were autoradiographed for 2 h using Kodak X-Omat AR films. Lanes 1-10 respectively show the amplification products from (Figure 4a ), Southern blotting of the amplified fragments (270 bp) after hybridization with-the labelled SERCA2b probe showed that, again as expected, identical amounts of SERCA2b mRNA were present in all cell lines tested (lanes 1-10) . Figures   * 4d4M 4~-~. ---..--. 4(b) and 4(c) respectively show the Southern blots resulting from hybridization at high stringency of the amplified fragments of raplA and raplB (362 bp) with the respective labelled probes. The haemopoietic cell lines exhibited different amounts ofmRNA for raplA and rapl B: Dami and HL-60 cells (Figure 4b, lanes 1  and 3) contained the most raplA, and HEL cells, the most raplB ( Figure 4c, lane 2) . In contrast, the tumour cell lines KATO III, MG-63, DU 4475, Y79 and SK-MEL-I (Figures 4b and 4c , lanes 6-10 respectively) seemed to possess identical and low mRNA levels for both raplA and raplB.
The mRNA levels of both raplA and raplB totally corroborated the results for total Rapl proteins and confirmed, at the RNA level, the relationship established between the 97 kDa SERCA and Rapl proteins. These results also explain why the HL-60 cell line constitutes an exception to the Rapl/97 kDa SERCA relationship, because it exhibits particularly high levels of RaplA, in agreement with previous reports [47, 48] . Finally, these results provide additional information about the identity of the Rap isoform involved in this relationship, as it seems that the correlation with the 97 kDa SERCA involved RaplB rather than RaplA.
Comparative cAMP-induced phosphorylation of Rapl proteins As the mechanism governing the action of RapI proteins on the SERCAs is their cAMP-induced phosphorylation, it seemed essential to first study this functional property of Rapl B in the relationship with the 97 kDa SERCA, as only this isoform was found to be phosphorylated in platelets [32] . For this, we carried out cAMP-induced phosphorylation on membranes isolated from the selected representative cells, using C.Sub. The same experiments were conducted in the absence of C.Sub. to check the specificity of the phosphorylation by cAMP. Figure 5 shows the comparative results of a typical experiment. No phosphorylated RapI proteins were detected in the membranes of any cell type in the absence of C.Sub., as expected for these negative controls. Figure 5 further shows that the cAMP-induced major phosphorylation of the 24 [43] . Figure 6 shows the expression of 97 kDa SERCA and Rapl proteins in SHR and WKY rat platelet membranes, as revealed by Western blotting. Figure 6(a) shows that the amount of 97 kDa SERCA was larger in SHR platelets (lane 2) than in normal platelets (lane 1), as previously observed [43] . Figure 6( To discriminate between RaplA and Rap lB and to ascertain if one of them is preferentially co-expressed with the 97 kDa SERCA, we studied the expression of each isoform at the RNA level by RT-PCR, and, for the Rap lB isoform, by testing the extent of its phosphorylation by cAMP [32] . The results of the RT-PCR experiments were indeed consistent with differential expression of the two isoforms in the various cell lines, although they were both present in all the cells studied. This fits with the results of Culine et al. [52] who reported that both raplA and raplB mRNAs were expressed in all the human tumours and cell lines they tested. Also a more recent study showed the presence of immunoreactivity against the RaplA and Rap lB isoforms in the membranes of several cell lines [48] . In addition, the present differential expression of raplA and raplB was consistent with the fact that only the expression of raplB correlated with that of the 97 kDa SERCA. The [58, 59] . Thirdly, the present study provides a basis for further exploration of the action mechanism of this regulation, as the two protein entities involved have now been identified. Our findings define the specific nature of the tools that will be required for this exploration, such as isoform-specific antibodies to both the 97 kDa SERCA and RaplB proteins. The present identification of the proteins concerned is also particularly important with regard to the recent controversy about the potential regulation of platelet Ca2I-ATPase (see the Introduction). Indeed, Fischer and White [22] failed to detect a 100 kDa platelet SERCA in a complex formed by cross-linking the 24 kDa phosphoprotein with platelet microsomes. This result can be explained by the use of an anti-SERCAI antibody, and we demonstrate in this study that the protein involved is the 97 kDa SERCA and not SERCA1.
In addition, the present work has established beyond a doubt that the two platelet SERCAs are quite distinct. Previously, the 97 kDa SERCA was found to differ from the 100 kDa SERCA on the basis of its specific recognition by a platelet antibody, its particular trypsin fragmentation and its higher sensitivity to the newly described Ca2+-ATPase inhibitors [9] , but it was difficult to rule out the possibility that the 97 kDa isoform might constitute a proteolytic fragment of the 100 kDa isoform. Here, however, we have shown its specific up-regulation in SHR platelets and its absence from cell lines that express the 100 kDa SERCA2b isoform equally, so the distinction between the two Ca2+-ATPases can no longer be questioned.
Finally, these data agree with the idea that the 97 kDa SERCA might be the as yet unidentified SERCA3 protein. We have clearly demonstrated that epithelial cells express the 97 kDa SERCA protein, and it has recently been shown by in situ hybridization that SERCA3 is mainly present in endothelial cells (A. M. Lompre, personal communication), which have the same clonal origin as haemopoietic and epithelial cells. Thus it has strengthened the potential identity of the 97 kDa SERCA as being SERCA3, the cDNA of which was recently described [60] , and its definitive identification in platelets is in progress.
In conclusion, the relationship established here between the 97 kDa SERCA isoform and the RaplB protein constitutes a step forward in the understanding of the respective roles of the Rapl isoforms, especially in megakaryocytic cells which exhibit particularly high levels of these proteins.
